Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Reexamination Certificate
2007-01-05
2010-10-26
Jones, D L (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
C424S001110, C424S001650, C424S001810, C424S001850, C424S001890, C424S009100, C424S009300
Reexamination Certificate
active
07820144
ABSTRACT:
Disclosed are cannabimimetic aminoalkylindole compounds and methods for their manufacture. The disclosed compounds are surprisingly potent and selective cannabinoids. The disclosed compounds may include radioactive atoms. Also disclosed are methods of using the disclosed compounds, including use of the disclosed compounds to stimulate a cannabinoid receptor, to provide a physiological effect in an animal or individual, to treat a condition in an animal or individual and for use in radioimaging.
REFERENCES:
patent: 6900236 (2005-05-01), Makriyannis et al.
patent: 7173027 (2007-02-01), Makriyannis et al.
Deng Hongfeng
Makriyannis Alexandros
Alix Yale & Ristas, LLP
Jones D L
University of Connecticut
LandOfFree
Receptor selective cannabimimetic aminoalkylindoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor selective cannabimimetic aminoalkylindoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor selective cannabimimetic aminoalkylindoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191074